Caricamento in corso... Attendere.
Profilo società
Fagron N.V. specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The group ensures the sale of pharmaceutical formulas and raw materials, provides third-party pharmaceutical compounding services to pharmacists and hospitals, etc.
Fonte:
Cofisem
-
Ultimo aggiornamento:
13 Mar 2025
Dirigenti principali
| Chief Executive Officer | Rafael Padilla | ||||
| Chief Financial Officer | Karin Jong | ||||
| Chief Operating Officer | Vera Bakker | ||||
| Head of Investor Relations | Karen Berg | ||||
| General Counsel | Johan Verlinden | ||||
| Fonte: Cofisem - Ultimo aggiornamento: 13 Mar 2025 | |||||
Dati principali
| Millenium | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Net sales | 871.960 | 762.991 | 683.881 | 573.808 | 555.971 |
| Income from ordinary activities | 871.960 | 762.991 | 683.881 | 573.808 | 555.971 |
| Operating income | 130.696 | 108.633 | 97.909 | 87.438 | 88.738 |
| Cost of financial indebtedness net | 17.438 | 15.156 | 10.620 | 8.006 | 13.549 |
| Equity-accounted companies contribution to income | |||||
| Net profit from discontinued activities | |||||
| Net income | 81.001 | 71.044 | 70.066 | 61.379 | 60.037 |
| Net income (Group share) | 80.554 | 70.547 | 69.612 | 61.004 | 59.601 |
| Fiscal year end | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | IFRS | IFRS | IFRS | IFRS | IFRS |
| Fonte: Cofisem - Ultimo aggiornamento: 13 Mar 2025 | |||||
Informazioni sull’azionariato
Indirizzo
Fagron N.V.
Venecoweg 20A
BE-9810
Nazareth
Belgium
Telefono:
+32 88 33 11 288
Fax:
+32 88 33 11 210
Fonte:
Cofisem
-
Ultimo aggiornamento:
13 Mar 2025